Kidswell Bio Corporation
TSE:4584
Kidswell Bio Corporation
Income from Continuing Operations
Kidswell Bio Corporation
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
K
|
Kidswell Bio Corporation
TSE:4584
|
Income from Continuing Operations
-¥1.2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-12%
|
GNI Group Ltd
TSE:2160
|
Income from Continuing Operations
¥9.5B
|
CAGR 3-Years
91%
|
CAGR 5-Years
118%
|
CAGR 10-Years
N/A
|
|
PeptiDream Inc
TSE:4587
|
Income from Continuing Operations
¥3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Income from Continuing Operations
¥1.6B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
2%
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Income from Continuing Operations
¥4.8B
|
CAGR 3-Years
39%
|
CAGR 5-Years
39%
|
CAGR 10-Years
40%
|
|
S
|
StemRIM Inc
TSE:4599
|
Income from Continuing Operations
¥168.4m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Kidswell Bio Corporation's Income from Continuing Operations?
Income from Continuing Operations
-1.2B
JPY
Based on the financial report for Dec 31, 2023, Kidswell Bio Corporation's Income from Continuing Operations amounts to -1.2B JPY.
What is Kidswell Bio Corporation's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-12%
Over the last year, the Income from Continuing Operations growth was -90%. The average annual Income from Continuing Operations growth rates for Kidswell Bio Corporation have been -3% over the past three years , -6% over the past five years , and -12% over the past ten years .